By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Amarantus BioSciences, Inc.  

675 Almanor Avenue

Sunnyvale  California  94085  U.S.A.
Phone: 408-737-2734 Fax: 408-852-4427



Company News
Amarantus BioSciences Announces Publication Of Human Clinical Data For Engineered Skin Substitute In The Treatment Of Life-Threatening Pediatric Severe Burns 8/8/2016 11:21:30 AM
Amarantus BioSciences Announces Upcoming Investor Presentations 5/27/2016 10:23:31 AM
Amarantus BioSciences Announces Capital Infusion 4/25/2016 6:46:30 AM
Amarantus BioSciences Announces Cancellation Of Special Meeting Of Shareholders 3/22/2016 1:05:01 PM
Amarantus BioSciences Appoints Brian E. Harvey, MD PhD To Strategic Advisory Board 3/7/2016 6:56:58 AM
Amarantus BioSciences Receives Notices Of Allowance From European Patent Office For MANF And CDNF In The Treatment Of Retinal Disorders 2/29/2016 6:37:16 AM
Amarantus BioSciences To Present At Source Capital Group's 2016 Disruptive Growth & Healthcare Conference 2/10/2016 10:08:03 AM
Amarantus BioSciences Receives Orphan Drug Designation From The US FDA For Eltoprazine In The Treatment Of Parkinson's Disease Levodopa-Induced Dyskinesia 2/10/2016 6:12:10 AM
Amarantus BioSciences Requests Rare Pediatric Disease Designation From US FDA For MANF In The Treatment Of Retinitis Pigmentosa 2/5/2016 6:53:09 AM
Amarantus BioSciences Receives Dual Notices Of Allowance From European Patent Office For Engineered Skin Substitute (ESS) 2/3/2016 7:36:01 AM